Ruiz NM, Bessen LJ, Manion DJ et al. (1999), Potential adverse experiences associated with efavirenz(Drug information on efavirenz) (EFV, Sustiva(tm)) in adults. Abstract 655. Presented at the 6th Conference on Retroviruses and Opportunistic Infections. Chicago; Feb. 3.
Sacktor N, Lyles RH, Skolasky R et al. (2001), HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56(2):257-260.
Saykin AJ, Janssen RS, Sprehn GC et al. (1988), Neuropsychological dysfunction in HIV-infection: characterization in a lymphadenopathy cohort. International Journal of Clinical Neuropsychology 10(2):81-95.
Snider WD, Simpson DM, Nielsen S et al. (1983), Neurological complications of acquired immunodeficiency syndrome: analysis of 50 patients. Ann Neurol 14(4):403-418.
Working Group of the American Academy of Neurology AIDS Task Force (1991), Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 41(6):778-785 [see comment].
Wright JM, Sachdev PS, Perkins RJ, Rodriguez P (1989), Zidovudine(Drug information on zidovudine)-related mania. Med J Aust 150(6):339-341.
